Shree Pacetronix has opened a special window for the transfer and dematerialization of physical shares, providing shareholders an opportunity to regularize holdings bought or sold before April 1, 2019. The facility, which will remain open until February 4, 2027, follows a SEBI circular dated January 30, 2026, and aims to address pending transfer requests for physical securities.

The company specified that only requests accompanied by original share certificates, transfer deeds, and relevant supporting documents will be considered under this special window. Securities transferred through this process will be mandatorily credited to the transferee in dematerialized form and will be subject to a one-year lock-in period from the date of transfer registration. During this lock-in period, the securities cannot be transferred, lien-marked, or pledged.

Eligibility Criteria

Shareholders can determine their eligibility to lodge requests during the current window based on the execution date of the transfer deed and the availability of original security certificates. The company provided a matrix to clarify the applicability of the lodgement facility.

Contact Information

Shareholders with queries regarding the special window or the transfer process have been directed to contact the company's Registrar and Share Transfer Agents (RTA), Ankit Consultancy Pvt Ltd. Queries can be sent via email to investor@ankitonline.com or addressed to their office at 60, Electronic Complex, Pardeshipura, Indore (MP)-452010. Alternatively, shareholders may contact the company directly at pacetronix@hotmail.com for further assistance.

Shree Pacetronix Limited reported a consolidated net profit of ₹314.39 lakh for the financial year ended March 31, 2026, a significant increase from ₹74.99 lakh in the previous year. Revenue from operations for the year stood at ₹2176.01 lakh, compared to ₹1680.32 lakh in FY25. The Board of Directors approved the audited standalone and consolidated financial results during a meeting held on May 25, 2026.

The standalone net profit for FY26 was ₹301.74 lakh, while profit for the quarter ended March 31, 2026, was ₹97.05 lakh. Earnings per share (EPS) on a consolidated basis for the year increased to ₹8.66 from ₹2.08 in the prior year. The company’s sole business segment is "Life Saving Devices".

Auditor Appointments and Governance

Based on the Audit Committee's recommendation, the Board appointed M/s Apeksha Medatwal & Associates as the Internal Auditor for FY27, replacing M/s Shreyash Sethiya & Associates. The Board also approved the appointment of M/s Agarwal Patel & Sinhal as Statutory Auditors for a period of five years, commencing from the conclusion of the 38th Annual General Meeting until the conclusion of the 43rd Annual General Meeting, subject to shareholder approval.

The Board recommended specific Material Related Party Transactions (RPTs) for shareholder approval. The meeting, which commenced at 3:00 P.M. and concluded at 7:30 P.M., also covered other operational, financial, and administrative matters.

Financial Highlights

The following table summarizes the key financial metrics for the standalone and consolidated entity for the year ended March 31, 2026:

The statutory auditor, M/s S. R. Naredi & Co., issued an unmodified opinion on the standalone and consolidated financial results. The company also declared that the statutory auditor did not express any modified opinion or audit qualification in the audit report accompanying the annual audited financial statements.